| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
|
|
|
||||||||
|
||||||||||
Clinical Investigations |
1 First Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
2 Department of Laboratory Medicine, Yamagata University School of Medicine, Yamagata, Japan
3 Department of Radiology, Yamagata University School of Medicine, Yamagata, Japan
Scintigraphic evaluation of 123I-metaiodobenzylguanidine (123I-MIBG) in the lungs is considered to recognize endothelial cell lesions. The aim of this study was to clarify the involvement of the pulmonary microvascular injury in the pathogenesis of chronic obstructive pulmonary disease (COPD). Methods: We investigated lung 123I-MIBG kinetics and clinical indices in 25 COPD patients and 12 control subjects. Mean uptake ratios of lung to mediastinum (L/M) were calculated in anterior planer images at 30 min (early image) and 270 min (delayed image) after intravenous injection of 123I-MIBG. Pulmonary mean washout rate (WR) of the 123I-MIBG was also calculated. Results: The L/M ratios in both early and delayed images of COPD patients, as well as its WR, were significantly lower than those of the control subjects (L/M early: 1.26 ± 0.18 vs. 1.54 ± 0.11, P < 0.0001; L/M delayed: 1.20 ± 0.12 vs. 1.33 ± 0.09, P < 0.001; WR: 27.4% ± 5.3% vs. 34.2% ± 5.7%, P < 0.01). There were significant relationships between lung WR of the 123I-MIBG and other diagnostic tests for the severity of COPD, such as forced expiratory volume in 1 s (% FEV1.0: r = 0.386, P < 0.05), carbon monoxide diffusing capacity/alveolar volume (DLCO/VA: r = 0.449, P < 0.01), arterial blood oxygen pressure (PaO2: r = 0.474, P < 0.01), alveolar–arterial oxygen tension gradient [A–a]DO2 (r = -0.446, P < 0.01), and percentage of low-attenuation area (r = -0.458, P < 0.01) in the study population. Conclusion: Because lung WR of the 123I-MIBG is considered to be independent of an alteration of the pulmonary vascular surface area, these results suggest that the microvascular endothelial cell injury plays a significant role in the pathogenesis of COPD.
Key Words: chronic obstructive pulmonary disease • 123I-metaiodobenzylguanidine • microvascular endothelial cell injury
This article has been cited by other articles:
|
|
 |
|
  M. F. Vidal Melo, T. Winkler, R. S. Harris, G. Musch, R. E. Greene, and J. G. Venegas Spatial Heterogeneity of Lung Perfusion Assessed with 13N PET as a Vascular Biomarker in Chronic Obstructive Pulmonary Disease J. Nucl. Med., January 1, 2010; 51(1): 57 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. C. Burghuber and A. Valipour Knowing Chronic Obstructive Pulmonary Disease by Heart: Cumulating Evidence of Systemic Vascular Dysfunction Am. J. Respir. Crit. Care Med., September 15, 2009; 180(6): 487 - 488. [Full Text] [PDF]
|
|
|
|
|
|
N. Takabatake, Y. Shibata, S. Abe, T. Wada, J.-i. Machiya, A. Igarashi, Y. Tokairin, G. Ji, H. Sato, M. Sata, et al. A Single Nucleotide Polymorphism in the CCL1 Gene Predicts Acute Exacerbations in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 875 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Lee, B.-H. Ko, J.-Y. Paik, K.-H. Jung, J.-S. Bae, J.-Y. Choi, Y. S. Choe, and B.-T. Kim Characteristics and Regulation of 123I-MIBG Transport in Cultured Pulmonary Endothelial Cells J. Nucl. Med., March 1, 2006; 47(3): 437 - 442. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
